- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 2.2 EX-2.2
- 5.1 EX-5.1
- 8.1 EX-8.1
- 8.2 EX-8.2
- 10.54 EX-10.54
- 10.55 EX-10.55
- 10.56 EX-10.56
- 10.57 EX-10.57
- 10.58 EX-10.58
- 10.59 EX-10.59
- 10.60 EX-10.60
- 10.61 EX-10.61
- 10.62 EX-10.62
- 10.63 EX-10.63
- 10.64 EX-10.64
- 10.65 EX-10.65
- 10.66 EX-10.66
- 10.67 EX-10.67
- 10.68 EX-10.68
- 10.69 EX-10.69
- 10.70 EX-10.70
- 10.71 EX-10.71
- 10.72 EX-10.72
- 23.1 EX-23.1
- 23.2 EX-23.2
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.8 EX-99.8
- 26 Apr 13 Registration of securities issued in business combination transactions
- 18 Jan 13 Registration of securities issued in business combination transactions (amended)
- 11 Dec 12 Registration of securities issued in business combination transactions
- 19 Aug 09 Registration of securities issued in business combination transactions (amended)
- 7 Aug 09 Registration of securities issued in business combination transactions
EXHIBIT 99.1
The Board of Directors
BioSante Pharmaceuticals, Inc.
111 Barclay Boulevard
Lincolnshire, IL 60069
Members of the Board:
We hereby consent to (i) the inclusion of our opinion letter, dated October 3, 2012, to the Board of Directors of BioSante Pharmaceuticals, Inc. (“BioSante”) as Annex G to the Joint Proxy Statement/Prospectus which forms a part of the Registration Statement on Form S-4 of BioSante relating to the proposed merger of ANIP Acquisition Company with and into BioSante, and (ii) the references to such opinion in such Joint Proxy Statement/Prospectus under the headings “Summary—Opinion of Oppenheimer & Co. Inc.,” “The Merger—Background of the Merger,” “The Merger—BioSante Reasons for the Merger” and “The Merger—Opinion of Oppenheimer & Co. Inc.” By giving such consent, we do not thereby admit that we are experts with respect to any part of such Registration Statement within the meaning of the term “expert” as used in, or that we come within the category of persons whose consent is required under, the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission promulgated thereunder.
| OPPENHEIMER & CO. INC. |
|
|
|
|
| December 11, 2012 |